Furthermore, considering the association of preoperative levels with clinical outcome, VCAM1 has been suggested as a predictive biomarker for heart failure-related mortality and morbidity, endothelial injury in coronary artery disease and arrhythmias such as atrial fibrillation (33). This evidence concerns the gene VCAM1 and heart failure.